Researchers need clean, standardized access to age-reversal data to validate and build on this breakthrough.
Build a cloud API that normalizes and serves processed stem cell datasets with age metrics. Researchers could query by donor age, reversal efficiency, and cell type.
Academic labs and biotech companies would pay for high-quality datasets that save them lab work. Offer tiered pricing based on dataset size and analysis depth.
Start with a simple CSV export of the published data, then add query endpoints.
The biggest risk is slow adoption if the field moves to other biomarkers.